Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17701
Country/Region: South Sudan
Year: 2016
Main Partner: Columbia University
Main Partner Program: International Center for AIDS Care and Treatment Programs
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $2,917,520 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $228,697
Testing: HIV Testing and Counseling (HVCT) $473,506
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $60,355
Treatment: Adult Treatment (HTXS) $2,075,125
Treatment: Pediatric Treatment (PDTX) $79,837
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,807
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,512
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 12,313
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 8,208
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 23,840
HTS_TST Service Delivery Point (Facility): Other PITC 2017 11,920
HTS_TST Service Delivery Point (Facility): VCT 2017 11,920
HTS_TST Sum of Aggregated Age/Sex <15 2017 3,319
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 20,521
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 23,840
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 146
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 122
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 985
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 658
PMTCT_ART Already on ART at beginning of current pregnancy 2017 83
PMTCT_ART New on ART 2017 82
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 4,462
PMTCT_STAT By: Known positives at entry 2017 58
PMTCT_STAT By: Number of new positives identified 2017 58
PMTCT_STAT Number of new ANC and L&D clients 2017 4,958
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 4,462
PMTCT_STAT Sum of Positives Status disaggregates 2017 116
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 4
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 23
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 14
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 42
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 42
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 548
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 552
TB_SCREENDX Screen Result: Screened Positive for TB 2017 731
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 3,890
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 2,594
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 457
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 365
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 7,306
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 24
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 226
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 17
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 149
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 416
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 554
TX_CURR Aggregated Age/Sex: <15 Female 2017 37
TX_CURR Aggregated Age/Sex: <15 Female 2017 398
TX_CURR Aggregated Age/Sex: <15 Male 2017 28
TX_CURR Aggregated Age/Sex: <15 Male 2017 355
TX_CURR Aggregated Age/Sex: 15+ Female 2017 921
TX_CURR Aggregated Age/Sex: 15+ Female 2017 5,908
TX_CURR Aggregated Age/Sex: 15+ Male 2017 632
TX_CURR Aggregated Age/Sex: 15+ Male 2017 3,939
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 1,618
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 10,600
TX_CURR Sum of Aggregated Age/Sex <15 2017 65
TX_CURR Sum of Aggregated Age/Sex <15 2017 753
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 1,553
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 9,847
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 1,618
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 10,600
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 23
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 240
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 19
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 200
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 581
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 2,394
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 441
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,596
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,064
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 4,882
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,064
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 4,430
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 143
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 131
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,768
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,189
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 3,231
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 4,430
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 240
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 200
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,394
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,596